The Canadian healthcare system must be restructured such that Canadians have equitable access to evidence-based, effective, medically necessary drugs, including access to the expertise of pharmacists, regardless of their care setting and of their ability to pay.

CSHP has been a long-standing proponent of Pharmacare. In this joint statement, published November 19, 2019, CSHP calls on the new federal government to immediately implement universal, public pharmacare.

Read the Statement

CSHP's Position

National Pharmacare: Position Statement (2017)


Medications are a crucial part of preventing and treating illness. Unfortunately there are barriers to their accessibility and appropriate use in Canada. A national pharmacare program and the creation of a national formulary would go a long way to ensuring that all Canadians have equitable access to safe and effective medically necessary drugs, regardless of where they live.

Key Messages from CSHP

Endorsement of the Pharmacare Consensus Principles

  • Joined over 80 other organizations

Position Statement

Pharmacare NOW (2019) National Pharmacare: Position Statement (2017) Régime national d’assurance médicaments : Déclaration de principes (2017)

Letter to Prime Minister Justin Trudeau and the Provincial and Territorial Premiers – 2016

National Pharmacare Plan – Open Letter Régime national d’assurance médicaments : lettre ouverte


"The National Pharmacare Debate": Brief to the Provincial, Territorial, and Federal Ministers of Health – 2004 “Prescription for the Future”: Brief to the Commission on the Future of Health Care in Canada – 2002

What's New

Interim Report from the Advisory Council on the Implementation of National Pharmacare. (March 5, 2019). Government of Canada.

Federal Cost of a National Pharmacare Program (September 28, 2017). Government of Canada. Office of the Parliamentary Budget Officer.

Follow-up analysis to "Federal Cost of a National Pharmacare Program" (November 8, 2017). Government of Canada. Office of the Parliamentary Budget Officer.